News

ivWatch Partners with National Infusion Center Association (NICA)

ivWatch, LLC, the IV safety company, today announced that it has partnered with the National Infusion Center Association (NICA), an independent, nonprofit trade association and accrediting body dedicated to representing ambulatory outpatient care settings where provider-administered biologics and specialty medications are prepared and administered.

In alignment, ivWatch and NICA are partnering with an emphasis on providing innovative and accessible solutions to freestanding infusion centers and their patients. The proprietary patient monitoring technology from ivWatch allows patients to have continuous IV site monitoring during infusions in the comfort and convenience of an outpatient setting.

“NICA has been the nation’s voice for independent infusion centers for more than a decade, overcoming countless barriers to care and access obstacles on behalf of patients and dedicated to ensuring that the nation’s infusion centers remain a safe, efficient, and cost-effective means of receiving consistent, high-quality care,” notes Brian Nyquist, MPH, NICA President and CEO. “We are excited to have ivWatch on board in 2024 as our trusted partner in helping our industry remain on the cutting edge of patient safety innovation.”

“Infusion centers are on the frontlines of IV patient safety, so this partnership is a natural fit,” says Erin Wendell, chief marketing officer at ivWatch. “It is also a perfect opportunity to work with this fast-growing segment of the healthcare industry in advocating for the increased adoption that a monitoring technology can play in reducing the severity of IV injuries while also mitigating the liability risks associated with IV extravasation and infiltration.”

This partnership comes at a monumental time of global adoption for ivWatch, as the company expands its reach to patients in all care areas that provide essential infusions. The company recently filed for 510(k) clearance for iron-based infusions to better protect patients not only from IV injuries but also the specific lifelong effects of irreversible skin staining that occurs with iron extravasations.

NICA and ivWatch will collaborate on several educational webinars relevant to infusion centers, including the recognition and interventions of early stages of IV extravasations to help promote safer delivery of IV therapy. The company will also exhibit at NICA’s annual conference on June 21-22, 2024, at the MGM Grand in Las Vegas in Booth 207. ivWatch will be a key participant at the exclusive NICA Infusion Center of Excellence (NICE) Experience, which provides an insider look at the ideal infusion center model. Products and technologies that improve patient care and promote patient safety will be displayed prominently. The event will provide a firsthand immersive experience for clinicians, administrators, managers, and owners.

 

Learn more here.

Recent News

04/23/2025

Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the successful completion of a new round of growth equity capital. These developments support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories

04/22/2025

Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America

Phlow Corp., a leading pharmaceutical contract development and manufacturing organization (CDMO) in America, announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure. Marking a period of exceptional growth and momentum, Phlow has more than doubled in size and now employs over 90+ highly skilled scientists and professionals

04/22/2025

ATCC Announces New Executive Leadership Appointments

ATCC, the world’s premier biological materials management and standards organization, today announced several new leadership appointments. Rebecca Bradford, MBA, has been promoted to the role of senior vice president of Government Programs, ATCC Federal Solutions (AFS); Manoj Menon, PhD, has joined the company as chief operating officer; and Rupali Lach was appointed vice president of Commercial Operations.